These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3649527)

  • 1. [Research on antiviral antibodies of human immunodeficiency and markers of hepatitis B in polytransfused renal patients subjected to chronic hemodialysis].
    Romero MS; Lasierra P; Larrad L; Gutiérrez M
    Med Clin (Barc); 1987 May; 88(17):698-9. PubMed ID: 3649527
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution of new markers to the diagnosis of hepatitis in dialysis].
    Matesanz R; Quereda C; Marcén R; Orofino L; Fernández Muñoz R; Bueno Vallejos R; González Sainz J; Ortuño J
    Rev Clin Esp; 1980 Nov; 159(3):171-5. PubMed ID: 7465895
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B virus markers among family contacts and medical personnel of 239 hemodialysis patients.
    Gahl GM; Vogl E; Kraft D; Hess G; Arnold W
    Clin Nephrol; 1980 Jul; 14(1):8-12. PubMed ID: 7408256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations concerning anti-HBs in transfusion blood and application of anti-hepatitis B immunoglobulin concentrations in the prevention of hepatitis B].
    van Loghem JJ
    Ned Tijdschr Geneeskd; 1979 Oct; 123(43):1874-5. PubMed ID: 514376
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple hepatitis B virus markers in dialysis patients.
    Acchiardo S; Cockrell S
    Trans Am Soc Artif Intern Organs; 1982; 28():308-11. PubMed ID: 7164253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frequency of HBs antibodies in various categories of examinees].
    Drobnjaković A; Kaljalović R; Antić M; Odavić M; Marinković V; Stanković D; Tasić B; Radović M; Birtasević B
    Vojnosanit Pregl; 1977; 34(5):322-6. PubMed ID: 602056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of anti-HTLV-III antibodies in a population of polytransfused patients subjected to hemodialysis].
    Alonso Hernández A; Lueiro F; Sánchez-Guisande Jack D; Pereira García A
    Med Clin (Barc); 1986 Oct; 87(10):436-7. PubMed ID: 3465982
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
    Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
    Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum markers of B virus in chronic active hepatitis].
    Segovia E; Rattoni N; Landa L
    Rev Gastroenterol Mex; 1981; 46(1):23-6. PubMed ID: 7280459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Viral infections in patients on chronic hemodialysis].
    Petrović R; Stojković-Svirtlih N; Zerjav S; Milosavljević M; Todorović Z
    Srp Arh Celok Lek; 1987; 115(5-6):589-94. PubMed ID: 2855894
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroconversion rate, hepatitis B vaccination, hemodialysis, and zinc supplementation.
    Rawer P; Willems WR; Breidenbach T; Guttmann W; Pabst W; Schütterle G
    Kidney Int Suppl; 1987 Oct; 22():149-52. PubMed ID: 3481000
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatitis B virus in a hemodialysis unit].
    Guma CL; Colombato LO; Alvarez E; Franco CO; Planes N
    Medicina (B Aires); 1985; 45(5):491-5. PubMed ID: 3842456
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation.
    Adorno D; Valeri M; Piazza A; Bonini S; Papola F; Casciani CU
    Transplant Proc; 1979 Jun; 11(2):1269-70. PubMed ID: 382505
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
    Turci F; Iosa G; Cipolloni A; Cenciotti L
    Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral markers of acute hepatitis].
    Jirón MI; Armas Merino R; Ramón Soto J; Wolff C
    Rev Med Chil; 1982 Dec; 110(12):1234-6. PubMed ID: 7184111
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination against hepatitis B in patients on chronic hemodialysis.
    Kovacic V; Sain M; Vukman V
    Saudi Med J; 2003 Mar; 24(3):311. PubMed ID: 12704514
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-A, non-B hepatitis in patients with chronic hemodialysis].
    Bansky G; Grob PJ; Joller-Jemelka HI; Zaruba K; Iselin H; Gloor HJ
    Schweiz Med Wochenschr; 1984 Oct; 114(41):1423-7. PubMed ID: 6436969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
    Realdi G; Alberti A; Rugge M; Bortolotti F; Rigoli AM; Tremolada F; Ruol A
    Gastroenterology; 1980 Aug; 79(2):195-9. PubMed ID: 7399226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.